Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CASR | P41180 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorhexidine SCHEMBL4173718 | 0.94 | CNR1 (0.48) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL2297671 | 0.93 | ALDH1A1 (0.51) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL245334 | 0.93 | ALDH1A1 (0.51) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL2152457 | 0.93 | CNR1 (0.47) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL4250265 | 0.93 | SMN1; SMN2 (0.45) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL247105 | 0.92 | LMNA (0.45) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL12044 | 0.92 | CNR1 (0.48) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL2975320 | 0.92 | CNR1 (0.48) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL2975314 | 0.92 | CNR1 (0.48) | CNR1ALDH1A1POLBFOLH1SLC6A3 | |
| Chlorhexidine SCHEMBL12043 | 0.92 | CNR1 (0.48) | CNR1ALDH1A1POLBFOLH1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7179849-B2 | Antimicrobial compositions containing colloids of oligodynamic metals | C. R. BARD, INC. (US) | 2007-02-20 | — | — | US | claimed |
| EP-0788305-A4 | COMPOSITION FOR INACTIVATING IRRITANTS IN FLUIDS | UNIV COLUMBIA (US) | 1999-05-26 | — | — | EP | claimed |
| JP-H09510976-A | — | — | 1997-11-04 | — | — | JP | claimed |
| EP-0788305-A1 | COMPOSITION FOR INACTIVATING IRRITANTS IN FLUIDS | The Trustees of Columbia University in the City of New York (US) | 1997-08-13 | — | — | EP | claimed |
| WO-1995026134-A1 | COMPOSITION FOR INACTIVATING IRRITANTS IN FLUIDS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1995-10-05 | — | — | WO | claimed |
| EP-4192531-A1 | FORTIFIED SANITIZING COMPOSITION HAVING ANTIMICROBIAL CHARACTERISTICS | 2 V Industries, Inc. (US) | 2023-06-14 | — | — | EP | disclosed |
| EP-3500102-B1 | ANTI-MICROBIAL COMPOSITION | BYOTROL PLC (GB) | 2023-06-07 | — | — | EP | disclosed |
| US-20230152311-A1 | Analyte Test Strip Assays, and Test Strips and Kits for Use in Practicing the Same | BECTON, DICKINSON AND COMPANY | 2023-05-18 | — | — | US | disclosed |
| CN-109890955-B | Antibacterial agent-resistant lactic acid bacteria | AB生物有限公司 | 2023-05-09 | — | — | CN | disclosed |
| US-20230034034-A1 | LOW-VOC CLEANING SUBSTRATES AND COMPOSITIONS | THE CLOROX COMPANY | 2023-02-02 | — | — | US | disclosed |
| EP-2948256-B1 | ANTISEPTIC APPLICATOR | CAREFUSION 2200 INC (US) | 2022-12-14 | — | — | EP | disclosed |
| CN-109561694-B | Antimicrobial compositions | 拜奥特罗尔有限公司 | 2022-09-27 | — | — | CN | disclosed |
| EP-0874655-A1 | TRICLOSAN-CONTAINING MEDICAL DEVICES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-11-04 | — | — | EP | disclosed |
| US-5772640-A | INTRAVENOUS CATHETER; IMPREGNATING THE CATHETER IN A SOLUTION CONTAING A SOLVENT, A CHLORHEXIDINE OR DERIVATIVES OR SALTS AS ANTISEPTIC, TRICLOSAM AND BIOMEDICAL POLYMER, SOAKING TO SWELL, REMOVING AND DRYING | THE TRUSTEES OF COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK (US) | 1998-06-30 | — | — | US | disclosed |
| US-5708023-A | NONIRRITATING GEL FOR SKIN | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1998-01-13 | — | — | US | disclosed |
| US-5705532-A | Triple antimicrobial composition | THE TRUSTEES OF COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK | 1998-01-06 | — | — | US | disclosed |
| EP-0788305-A1 | COMPOSITION FOR INACTIVATING IRRITANTS IN FLUIDS | The Trustees of Columbia University in the City of New York (US) | 1997-08-13 | — | — | EP | disclosed |
| WO-1997025085-A1 | TRICLOSAN-CONTAINING MEDICAL DEVICES | COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK (US) | 1997-07-17 | — | — | WO | disclosed |
| WO-1997017849-A1 | TRIPLE ANTIMICROBIAL COMPOSITION | THE TRUSTEES OF COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK (US) | 1997-05-22 | — | — | WO | disclosed |
| WO-1995026134-A1 | COMPOSITION FOR INACTIVATING IRRITANTS IN FLUIDS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1995-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230034034-A1 | LOW-VOC CLEANING SUBSTRATES AND COMPOSITIONS | SMURF1, VCL, SMURF2 | CNR1 2525/4885ALDH1A1 2579/4885POLB 944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.